Angelo Raggioli

Angelo Raggioli has a diverse work experience spanning various roles and industries. Angelo started their career at Università degli Studi di Napoli Federico II as a Bachelor Student from 2004 to 2006, followed by a Master Student role at Fondazione Telethon from 2006 to 2008. Angelo then joined the Max-Planck Institute of Immunobiology and Epigenetics as a Ph.D. Student and later as a Postdoctoral Fellow, where they focused on molecular profiling and protein-protein interaction validation from 2009 to 2013.

After that, Angelo worked at EMBL as a Lab Manager and was responsible for internalizing AAV production in the institute. Angelo also generated a library of AAV constructs and contributed to CRISPR experiments from 2014 to 2019.

In 2018, they worked as a Freelance Scientific and Medical Editor at Cactus Communications, where they edited and formatted manuscripts according to target journals' requirements.

From 2019 to the present, Angelo has held leadership positions at REITHERA, initially as the Head of Vectorology and later as the Head of Technology Development. In these roles, they managed a team of PhD-level scientists and executed pre-clinical projects related to cancer and viral infectious diseases. Angelo also provided scientific insights, delivered presentations to internal and external stakeholders, and supported the Regulatory Affairs and Clinical Trial departments.

Additionally, Angelo Raggioli joined BioExpert Network in 2021 as an Expert, contributing their expertise to the network.

Angelo Raggioli earned a Master's Degree in Cell/Cellular and Molecular Biology from Università degli Studi di Napoli Federico II, where they studied from 2002 to 2008. Angelo then pursued a Ph.D. in Developmental Biology and Embryology at The University of Freiburg from 2009 to 2013. In addition to their formal education, Angelo Raggioli obtained additional certifications in "Design and Interpretation of Clinical Trials" from The Johns Hopkins University in June 2020 and "Drug Development" from UC San Diego, also in June 2020.